4//SEC Filing
Kalnik Matthew W. 4
Accession 0001455244-10-000120
CIK 0000072444other
Filed
Jul 26, 8:00 PM ET
Accepted
Jul 27, 4:27 PM ET
Size
5.2 KB
Accession
0001455244-10-000120
Insider Transaction Report
Form 4
Kalnik Matthew W.
SVP Strategic Plan. & Bus. Ops
Transactions
- Sale
Common Stock
2010-07-26$5.78/sh−1,500$8,670→ 44,225.104 total
Footnotes (1)
- [F1]The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.
Documents
Issuer
NABI BIOPHARMACEUTICALS
CIK 0000072444
Entity typeother
Related Parties
1- filerCIK 0001459477
Filing Metadata
- Form type
- 4
- Filed
- Jul 26, 8:00 PM ET
- Accepted
- Jul 27, 4:27 PM ET
- Size
- 5.2 KB